NexImmune (NEXI) Revenue & Revenue Breakdown
NexImmune Revenue Highlights
00
NexImmune Revenue by Period
NexImmune Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | - |
NexImmune Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | - | -100.00% |
2023-12-31 | $2.12M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | - |
NexImmune Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
HOOK | HOOKIPA Pharma | $20.13M | - |
MREO | Mereo BioPharma Group | $10.00M | - |
XBIO | Xenetic Biosciences | $2.54M | $614.24K |
UNCY | Unicycive Therapeutics | $675.00K | - |
PALI | Palisade Bio | $250.00K | - |
SONN | Sonnet BioTherapeutics | $147.81K | - |
CNSP | CNS Pharmaceuticals | - | - |
PDSB | PDS Bio | - | - |
ZURA | Zura Bio | - | - |
INZY | Inozyme Pharma | - | - |
TERN | Terns Pharmaceuticals | - | - |
ZVSA | ZyVersa Therapeutics | - | - |
IMMX | Immix Biopharma | - | - |
RNAZ | TransCode Therapeutics | - | - |